ASPIC

envie a um amigo share this

Thyroid Nodule - can molecular tests improve fine-needle aspiration cytology diagnostic assessment?

Fine-needle aspiration (FNA) has high sensitivity and specificity in distinguishing benign from malignant thyroid lesions. However, in 5-20% of the cases belonging to the indeterminate cytology categories (follicular neoplasms and atypia of undetermined significance) it is not possible to discriminate between benign and malignant tumours. As a consequence of this limitation, patients with such diagnoses have to be submitted to diagnostic rather than to curative thyroid surgery.

Thyroid Nodule - can molecular tests improve fine-needle aspiration cytology diagnostic assessment?

Fine-needle aspiration (FNA) has high sensitivity and specificity in distinguishing benign from malignant thyroid lesions. However, in 5-20% of the cases belonging to the indeterminate cytology categories (follicular neoplasms and atypia of undetermined significance) it is not possible to discriminate between benign and malignant tumours. As a consequence of this limitation, patients with such diagnoses have to be submitted to diagnostic rather than to curative thyroid surgery.

Calcitonin receptor expression in medullary thyroid carcinoma

Medullary thyroid carcinoma (MTC) is a rare tumor representing 5–10% of thyroid cancers, with a 10-year survival rate is about 50–75%. It arises from a particular thyroid cell type: the parafollicular C-cells of the thyroid which secrete calcitonin (CT). Serum CT is a very sensitive and specific method for diagnosing MTC, however, the potential role of calcitonin receptor (CTR) expression on tumor aggressiveness and prognosis remained to be explored.

Expressão do recetor da calcitonina nos carcinomas medulares da tiroide

O carcinoma medular da tiroide (CMT) é um tumor raro, representando cerca de 5-10% de todos os carcinomas da tiroide, com uma taxa de sobrevida livre de doença aos 10 anos de 50-75%. Este carcinoma provém de um tipo particular de células tiroideias, denominadas células C, produtoras de calcitonina (CT). Os níveis séricos de CT são um marcador de diagnóstico muito sensível e especifico dos CMT, no entanto, o potencial papel do recetor da calcitonina (RCT) relativamente à agressividade tumoral e prognóstico, permanece desconhecido.

Infection with Opisthorchis felineus induces intraepithelial neoplasia of the biliary tract in a rodent model

Authors and Affiliations:

Gouveia MJ1,2, Pakharukova MY3,4, Laha T5,6,7, Sripa B5,6,7, Maksimova GA3, Rinaldi G8, Brindley PJ8, Mordvinov VA3,9, Amaro T10, Santos LL10, Costa JMCD1,11, Vale N2,12.

 

1 Center for the Study in Animal Science, ICETA, University of Porto, Rua de D. Manuel II, Apt 55142, 4051-401 Porto, Portugal.

Infection with Opisthorchis felineus induces intraepithelial neoplasia of the biliary tract in a rodent model

Autores e Afiliações:

Gouveia MJ1,2, Pakharukova MY3,4, Laha T5,6,7, Sripa B5,6,7, Maksimova GA3, Rinaldi G8, Brindley PJ8, Mordvinov VA3,9, Amaro T10, Santos LL10, Costa JMCD1,11, Vale N2,12.

 

 

1 Center for the Study in Animal Science, ICETA, University of Porto, Rua de D. Manuel II, Apt 55142, 4051-401 Porto, Portugal.

In vitro targeting of colon cancer cells using spiropyrazoline oxindoles

Authors and Affiliations:

Rute C. Nunes, Carlos J. A. Ribeiro, Ângelo Monteiro, Cecília M. P. Rodrigues, Joana D. Amaral*, Maria M. M. Santos*

Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa. Av. Prof. Gama Pinto, 1649-003 Lisbon, Portugal

 

Abstract:

Descoberta de novas moléculas para actuar no cancro colo-rectal

O cancro colo-rectal é um dos cancros com maior taxa de incidência e de mortalidade no mundo. Em Portugal, viagra pas cher estima-se que 14.5% dos casos de cancro são de cancro colo-rectal, e que estes resultam em 15.7% das mortes por cancro, sendo urgente a descoberta de novos fármacos para o tratamento desta doença.

8th Innovation in Breast Cancer symposium

Auditorio Rafael del Pino, Madrid, Spain

 

23 - 24 February, 2018

 

See more informations here: http://www.innovationinbreastcancer.com/

8th Innovation in Breast Cancer symposium

Auditorio Rafael del Pino, Madrid, Spain

 

23 - 24 February, 2018

 

See more informations here: http://www.innovationinbreastcancer.com/